Insider Buy/Sell Details for the Healthcare Sector — August 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (808)
Edwards Lifesciences Corp (EW)
Lippis Daniel J. — CVP, TAVR
Shares
619
Price
$92.03
Total Value
$56.97K
Shares Held After
40,034
% of Holdings
1.5%
Korro Bio, Inc. (KRRO)
Lynx1 Capital Management LP — 10% Owner
Shares
1,462
Price
$13.19
Total Value
$19.28K
Shares Held After
1,544,980
% of Holdings
0.1%
TAKEDA PHARMACEUTICAL CO LTD (TAK)
Plump Andrew Stewart — Director
Shares
165,393
Price
$17.10
Total Value
$2.83M
Shares Held After
766,569
% of Holdings
17.7%
TAKEDA PHARMACEUTICAL CO LTD (TAK)
Pignagnoli Agosti Marcello — Head, Strat.&Port. Dev
Shares
22,957
Price
$17.10
Total Value
$392.56K
Shares Held After
176,977
% of Holdings
11.5%
TAKEDA PHARMACEUTICAL CO LTD (TAK)
Pacheco Rhonda Janice — President, U.S. Business Unit
Shares
16,901
Price
$17.10
Total Value
$289.01K
Shares Held After
182,507
% of Holdings
8.5%
TAKEDA PHARMACEUTICAL CO LTD (TAK)
Ibrahim Ramy Riad Ahmed — President, PDT BU
Shares
7,277
Price
$17.10
Total Value
$124.44K
Shares Held After
102,588
% of Holdings
6.6%
TAKEDA PHARMACEUTICAL CO LTD (TAK)
Farajallah Awny Samaan Botros — Chief Medical Officer
Shares
14,006
Price
$17.10
Total Value
$239.50K
Shares Held After
116,177
% of Holdings
10.8%
TAKEDA PHARMACEUTICAL CO LTD (TAK)
Duprey Lauren Rusckowski — Chief Transformation Officer
Shares
47,586
Price
$17.10
Total Value
$813.72K
Shares Held After
226,057
% of Holdings
17.4%
TAKEDA PHARMACEUTICAL CO LTD (TAK)
Platford Giles Richard — President, IBU
Shares
31,083
Price
$17.10
Total Value
$531.52K
Shares Held After
315,838
% of Holdings
9.0%
TAKEDA PHARMACEUTICAL CO LTD (TAK)
Greenway Nicola Deidre Petal — Chief Human Resources Officer
Shares
6,774
Price
$17.10
Total Value
$115.84K
Shares Held After
53,029
% of Holdings
11.3%
TAKEDA PHARMACEUTICAL CO LTD (TAK)
Furney Natalie Anne Marie — Global General Counsel
Shares
30,868
Price
$17.10
Total Value
$527.84K
Shares Held After
204,298
% of Holdings
13.1%
TAKEDA PHARMACEUTICAL CO LTD (TAK)
Kim Julie So-Young — Director
Shares
89,090
Price
$17.10
Total Value
$1.52M
Shares Held After
391,489
% of Holdings
18.5%
TAKEDA PHARMACEUTICAL CO LTD (TAK)
Ricci Gabriele — Chief Data&Tech. Officer
Shares
25,088
Price
$17.10
Total Value
$429.00K
Shares Held After
171,654
% of Holdings
12.8%
TAKEDA PHARMACEUTICAL CO LTD (TAK)
Shannon Elaine Mary — Pres., Global Supply&Quality
Shares
3,978
Price
$17.10
Total Value
$68.02K
Shares Held After
63,333
% of Holdings
5.9%
TAKEDA PHARMACEUTICAL CO LTD (TAK)
Bitetti Teresa Marie — President, OBU
Shares
50,012
Price
$17.10
Total Value
$855.21K
Shares Held After
252,010
% of Holdings
16.6%
Mineralys Therapeutics, Inc. (MLYS)
Rodman David Malcom — Chief Medical Officer
Shares
2,170
Price
$27.09
Total Value
$58.79K
Shares Held After
51,384
% of Holdings
4.1%
Adaptive Biotechnologies Corp (ADPT)
BOBULSKY SUSAN — Chief Commercial Officer, MRD
Shares
3,000
Price
$25.00
Total Value
$75.00K
Shares Held After
396,989
% of Holdings
0.8%
EXELIXIS, INC. (EXEL)
Beckerle Mary C — Director
Shares
9,812
Price
$53.66
Total Value
$526.51K
Shares Held After
16,079
% of Holdings
37.9%
BillionToOne, Inc. (BLLN)
ten Bosch John Roderick — SVP of Laboratory Operations
Shares
1,417
Price
$92.86
Total Value
$131.58K
Shares Held After
27,884
% of Holdings
4.8%
BillionToOne, Inc. (BLLN)
Tsao David — Director
Shares
10,000
Price
$92.86
Total Value
$928.60K
Shares Held After
1,000
% of Holdings
90.9%
Bausch&Lomb Corp (BLCO)
Munsch Frederick — SVP, Controller and CAO
Shares
52,900
Price
$16.78
Total Value
$887.66K
Shares Held After
45,831
% of Holdings
53.6%
Protagonist Therapeutics, Inc (PTGX)
PATEL DINESH V PH D — Director
Shares
65,761
Price
$149.11
Total Value
$9.81M
Shares Held After
523,478
% of Holdings
11.2%
BIODESIX INC (BDSX)
SCHULER JACK W — 10% Owner
Shares
13,900
Price
$24.25
Total Value
$337.03K
Shares Held After
527,110
% of Holdings
2.6%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
3,680
Price
$360.63
Total Value
$1.33M
Shares Held After
125,799
% of Holdings
2.8%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
21,254
Price
$359.50
Total Value
$7.64M
Shares Held After
129,479
% of Holdings
14.1%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
45,044
Price
$358.70
Total Value
$16.16M
Shares Held After
150,733
% of Holdings
23.0%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
15,869
Price
$357.67
Total Value
$5.68M
Shares Held After
195,777
% of Holdings
7.5%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
12,418
Price
$356.62
Total Value
$4.43M
Shares Held After
211,646
% of Holdings
5.5%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
3,476
Price
$355.66
Total Value
$1.24M
Shares Held After
224,064
% of Holdings
1.5%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
6,717
Price
$354.78
Total Value
$2.38M
Shares Held After
227,540
% of Holdings
2.9%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
3,673
Price
$353.32
Total Value
$1.30M
Shares Held After
234,257
% of Holdings
1.5%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
2,813
Price
$351.80
Total Value
$989.60K
Shares Held After
237,930
% of Holdings
1.2%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
67
Price
$350.00
Total Value
$23.45K
Shares Held After
240,743
% of Holdings
0.0%
Immunome Inc. (IMNM)
Barchas Isaac — Director
Shares
10,125
Price
$26.07
Total Value
$263.96K
Shares Held After
62,291
% of Holdings
14.0%
LifeStance Health Group, Inc. (LFST)
Paunovich Vukasin — Chief Technology Officer
Shares
44,394
Price
$10.85
Total Value
$481.67K
Shares Held After
247,446
% of Holdings
15.2%
Replimune Group, Inc. (REPL)
Patel Sushil — Director
Shares
39,341
Price
$12.97
Total Value
$510.25K
Shares Held After
708,151
% of Holdings
5.3%
TAKEDA PHARMACEUTICAL CO LTD (TAK)
Greenway Nicola Deidre Petal — Chief Human Resources Officer
Shares
33,628
Price
$17.51
Total Value
$588.72K
Shares Held After
59,803
% of Holdings
36.0%
TAKEDA PHARMACEUTICAL CO LTD (TAK)
Greenway Nicola Deidre Petal — Chief Human Resources Officer
Shares
975
Price
$17.50
Total Value
$17.06K
Shares Held After
93,431
% of Holdings
1.0%
908 Devices Inc. (MASS)
Brown Christopher D. — Director
Shares
9,442
Price
$9.03
Total Value
$85.26K
Shares Held After
813,917
% of Holdings
1.1%
Omada Health, Inc. (OMDA)
Gracey Craig — Chief Accounting Officer
Shares
1,042
Price
$25.00
Total Value
$26.05K
Shares Held After
15,441
% of Holdings
6.3%
Avalo Therapeutics, Inc. (AVTX)
Doyle Mittie — Chief Medical Officer
Shares
679
Price
$20.00
Total Value
$13.58K
Shares Held After
51,776
% of Holdings
1.3%
Merck&Co., Inc. (MRK)
DeLuca Richard R. — EVP&Pres, Merck Animal Heallth
Shares
20,784
Price
$130.43
Total Value
$2.71M
Shares Held After
134,703
% of Holdings
13.4%
Replimune Group, Inc. (REPL)
Xynos Konstantinos — Chief Medical Officer
Shares
11,447
Price
$12.97
Total Value
$148.47K
Shares Held After
224,215
% of Holdings
4.9%
Replimune Group, Inc. (REPL)
Schwendenman Andrew — Chief Accounting Officer
Shares
7,632
Price
$12.97
Total Value
$98.99K
Shares Held After
99,425
% of Holdings
7.1%
LifeStance Health Group, Inc. (LFST)
Miller Lisa K — Chief Operating Officer
Shares
47,912
Price
$10.85
Total Value
$519.85K
Shares Held After
281,289
% of Holdings
14.6%
LifeStance Health Group, Inc. (LFST)
TPG GP A, LLC — 10% Owner
Shares
13,643,207
Price
$10.62
Total Value
$144.89M
Shares Held After
98,101,407
% of Holdings
12.2%
INSMED Inc (INSM)
Adsett Roger — Chief Operating Officer
Shares
239,850
Price
$133.27
Total Value
$31.96M
Shares Held After
98,744
% of Holdings
70.8%
Omada Health, Inc. (OMDA)
Cook Steven L. — Chief Financial Officer
Shares
15,235
Price
$25.03
Total Value
$381.35K
Shares Held After
187,209
% of Holdings
7.5%
908 Devices Inc. (MASS)
Knopp Kevin J. — Director
Shares
348
Price
$9.06
Total Value
$3.15K
Shares Held After
732,255
% of Holdings
0.0%
Replimune Group, Inc. (REPL)
Hill Emily Luisa — Chief Financial Officer
Shares
11,448
Price
$12.97
Total Value
$148.48K
Shares Held After
225,108
% of Holdings
4.8%
Showing 101–150 of 808 transactions (page 3 of 17)